¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10
±³À°ÀÏÀÚ : 2024-05-10
±³À°Àå¼Ò : ¼ö¿øÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸

´ã´çÀÚ : ±èÇý¼÷
¿¬¶ôó : 02-512-5420

À̸ÞÀÏ : kelly.kim1436@hanmail.net

±³À°Á¾·ù : »êºÎÀΰú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í KGOG : Korean Gynecologic Oncology Group             »ç´Ü¹ýÀÎ ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ ¾àÀÚÀÔ´Ï´Ù.*ÇÁ·Î±×·¥¿¡ KGOG·Î µÇ¾îÀÖ´Â ºÎºÐ Âü°í ºÎŹµå¸³´Ï´Ù.


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:00~13:15 Data and Statistics Committee: Korean central IRB : suggestion for KGOG ÀÌ´ëÈ£(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:15~13:30 Data and Statistics Committee: Data management team build up experience ¾È¼Ò¿¬(ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 13:30~13:45 Establishing a foundation for activating investigator-initiated multi-center GYN cancer clinical trial group (2024' ~ 2028') ÃÖ¹Îö(ºÐ´çÂ÷º´¿ø)

Åä·Ð 05¿ù 10ÀÏ Room B 13:45~13:55 Discussion ±è±âµ¿, ÀÓÇöÁö(ºÐ´ç¼­¿ï´ëº´¿ø, ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 14:00~14:20 To understand overall global Trends in R&D 2024 and elements of Decentralized Clinical Trials(DCT): Global Trends in R&D 2024 È«Çö¼÷(IQVIA)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 14:20~14:40 Elements of Decentralized Clinical Trials and its Global Trends È«Çö¼÷(IQVIA)

Åä·Ð 05¿ù 10ÀÏ Room B 14:40~14:50 Discussion ()

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:00~14:05 KGOG 4004 (OVsurg-2102-1): A survey study of Peritonectomy (ÀÚÀ¯) ±è¸í¼±(¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:05~14:10 KGOG 4005 (OVsurg-2101): The analysis of the patients who have received reoperation whining 30 days after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer (ÀÚÀ¯) À¯ÇåÁ¾(¼¼Á¾Ãæ³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:10~14:15 KGOG 4006 (OVsurg-2103): The analysis of 90-day postoperative mortality after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer (ÀÚÀ¯) ¼Û¿ëÁß(ºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:15~14:20 KGOG 4010 (OVsurg-2108): Assessment of QoL after LAR or visceral peritoneal stripping during cytoreductive surgery for AEOC: prospective cohort study (LAPSODY) trial (ÀÚÀ¯) ±èÈñ½Â(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:20~14:25 Lymphadenectomy In clinically early epitheLial ovArian Cancer and survival analaysis (LILAC) (ÀÚÀ¯) ½É½ÂÇõ(°Ç±¹´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:25~14:30 Sentinel lymph node mapping in early stage ovarian cancer (ÀÚÀ¯) ±è´ë¿¬(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:30~14:35 OVsurg-2102-3: Total parietal peritonectomy during IDS/NACT for epithelial ovarian/fallopian tube/primary peritoneal carcinoma: A feasibility study (TPP-IDS) (ÀÚÀ¯) ÀÌÀºÁÖ(Á߾Ӵ뺴¿ø)

Åä·Ð 05¿ù 10ÀÏ Room C 14:35~14:40 Discussion ±èÀºÅÃ(°í½Å´ëÇб³)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 14:40~14:50 New Concept: OVsurg-2401 Intrathoracic approach of ovarian pleural metastasis (ÀÚÀ¯) ÀÌÁÖÇå(°æºÏ´ëº´¿ø)

Åä·Ð 05¿ù 10ÀÏ Room C 14:50~14:55 Discussion À±ÇüÁØ(ºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room A 15:00~15:40 Harnessing genomic insights in gynecological cancer in pursuit of improved patient outcome ¹Î°æÁø(°í´ë¾È»êº´¿ø)

Åä·Ð 05¿ù 10ÀÏ Room A 15:40~15:50 Discussion ±è¼º¹Î, À̽¹Ì(ÀÏ»êÂ÷º´¿ø, °è¸íÀǴ뵿»êÀÇ·á¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:00~16:10 Update of inclusion criteria discussed in the Steering Committee (ÀÚÀ¯) À̼ºÁ¾(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:10~16:25 Surgical video: da Vinci¢ç Robotic radical hysterectomy in the ROCC trial ¼ÛÀçÀ±(°í´ë¾È¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:25~16:30 Strategies for colpotomy and tumor containment: Creation of vaginal cuff and closure (ÀÚÀ¯) À̼ºÁ¾(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:30~16:35 Strategies for colpotomy and tumor containment: Tape (ÀÚÀ¯) ±è¼º¹Î(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:35~16:40 Strategies for colpotomy and tumor containment: Stapler (ÀÚÀ¯) °øÅ¿í(¾ÆÁִ뺴¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room C 16:40~16:45 Strategies for colpotomy and tumor containment: Uterine manipulation without Lumi (ÀÚÀ¯) ¹Ú¿µÇÑ(ÇѸ²¼º½Éº´¿ø)

Åä·Ð 05¿ù 10ÀÏ Room C 16:45~16:50 Discussion ±è¹Î±Ô(»ï¼ºÃ¢¿øº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:00~16:10 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) / 1. Current Status & future issues (ÀÚÀ¯) ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:10~16:30 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) /2. Protocol Updates (ver. 4.0) À±º¸¼º(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 16:30~16:40 Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial (DEBULK trial) /3. Tips for study procedure (ÀÚÀ¯) ¹®ÁöÇö(´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸)

Åä·Ð 05¿ù 10ÀÏ Room B 16:40~16:50 Discussion °øÅ¿í, ¼³¾Ö¶õ(¾ÆÁִ뺴¿ø, °í´ë¾È¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 17:00~17:10 Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer : 1. Current Status & Dummy run study (ÀÚÀ¯) À§Âù¿ì(¿¬¼¼¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 10ÀÏ Room B 17:10~17:20 Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer: 2. Suggestion of ¡°Pattern of care study on recurrent epithelial ovarian cancer (ÀÚÀ¯) ±èº¸¶ó(ÀÌ´ë¸ñµ¿º´¿ø)

Åä·Ð 05¿ù 10ÀÏ Room B 17:20~17:30 Discussion ÀÌ¿µÀç, À±ÇüÁØ(¼¼ºê¶õ½ºº´¿ø, ºÎ»ê´ëº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³âµµ Á¦71Â÷ ´ëÇÑÁ÷¾÷ȯ°æÀÇÇÐȸ º½Çмú´ëȸ : 2024-05-10
´ÙÀ½±Û 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 5 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 2 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 2 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 0 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 0 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 0 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 2 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 0 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 1 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 0 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷